IntegerBio

🦃 As we reflect this Thanksgiving, we have much to be thankful for. First, we are grateful for our remarkable team. Every day, this diverse group brings unmatched dedication, scientific expertise, and a passion for what's possible to our mission. To our partners, Scientific Advisory Board (https://lnkd.in/eCjRAAJy), and Board of Directors (https://lnkd.in/erEBwYm5) thank you for your vision, guidance, and support. Your unique perspectives and expertise are instrumental in realizing the potential of our work. We are grateful for the boundless potential of science, made possible by the dedication and expertise of those who transform ideas into breakthroughs that change the world. Together, we’re advancing #Immunovirology, creating solutions with the potential to tune the immune system against multi-viral diseases. This season, we celebrate all we’ve accomplished together and look forward to what’s to come. We are proud to be part of a dynamic industry that is shaping the future of healthcare. 🍂 From all of us at IntegerBio, Happy Thanksgiving! 🍂 #Thanksgiving #Gratitude #Innovation #Teamwork #PioneeringImmunovirology #IntegerBio

Proud to announce that IntegerBio was nominated for Start-Up of the Year by BioBuzz in the BioHealth Capital Region. The Team has made incredible strides this year and it's great to receive recognition. Please take a moment and vote for us!

🎉 We are thrilled to share that IntegerBio has been named a finalist for Start-Up of the Year in the 2024 BioBuzz Awards for the BioHealth Capital Region.  Congratulations to all the finalists! 🎉 This recognition is a testament to the hard work, dedication to scientific excellence, and innovative spirit of our team. Together, we’re advancing the science of #Immunovirology to develop multi-viral solutions —and this nomination is a celebration of our progress.  And we need your help! Voting is now open, and your vote can help us secure this award.   ✅ Vote for IntegerBio here: https://lnkd.in/emrVWFHt  ✅ Vote once a day from now until December 13, 2024.  ✅ Share this post and encourage your network to vote, too! Thank you for recognizing the momentum we’re building to pioneer immunovirology for the benefit of patients. Join us in celebrating the power of innovation and collaboration in the BioHealth Capital Region! We’re grateful to be part of a dynamic industry ecosystem with so many peers and friends doing such important work. #Innovation #Biotech #BioBuzzAwards #Vote #IntegerBio #PioneeringImmunovirology

Yesterday our CEO Atul Saran attended the Industry Day hosted by the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical in Alexandria, VA. This event offered a valuable opportunity to engage with key U.S. Government agencies, including Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense-JPEO-CBRND, Biomedical Advanced Research and Development Authority (BARDA), and the Joint Science and Technology Office as we aim to accelerate #outbreakreadiness for viral diseases. At IntegerBio we’re committed to harnessing the power of science to design multi-viral therapeutics that address the unmet needs of those most vulnerable to viral disease. By participating in discussions at Industry Day, we’re building on our mission to deliver solutions that protect public health. As we continue to advance cutting-edge solutions in #Immunovirology, we look forward to the opportunity to partner with like-minded peers and agencies. #HostDirectedTherapeutics #Innovation #GovernmentCollaboration #PublicHealth #Biotech #PioneeringImmunovirology #IntegerBio 

In case you missed us in Chicago last month: Pre-clinical data from Yueh-Ming Loo, PhD’s poster presentation at the Hepatitis B Foundation's 2024 International HBV Meeting revealed that SYN1 shows strong antiviral effects against HBV in both lab tests and live models, with the potential for improved safety and tolerability.  SYN1 is a treatment candidate being studied for its ability to effectively combat Hepatitis B (HBV), but also its potential to offer a safer, more tolerable option with fewer side effects for patients compared to current immune treatments. #pioneeringimmunovirology #IntegerBio #SYN1 #hepatitis #antiviral 

We are pleased to highlight the distinguished members of our Scientific Advisory Board. These highly regarded researchers, clinicians and drug developers bring a wealth of knowledge and experience to our drug development efforts. Each has demonstrated a life-long commitment to innovative scientific excellence in service of addressing the unmet medical needs of those affected by viral disease. With their expertise, we are primed to bring our novel solutions tuning the immune system against multi-viral diseases to patients as fast as possible.   We’re grateful for their expertise to help us achieve our simple, yet ambitious goal: To unleash the possibility of a future without the fear of viral disease.  Learn more at https://lnkd.in/eCjRAAJy #pioneeringimmunovirology #IntegerBio  Diana Brainard Sumit Chanda K. Christopher Garcia Robert Gish Camille Kotton Peter Openshaw

We are excited to announce the appointment of Eric Dobmeier as Chair of IntegerBio’s Board of Directors, effective October 1st, joining Srini Akkaraju, Abraham (Abe) Bassan, and CEO Atul Saran. Eric brings a wealth of governance and operating leadership in building and scaling biotech companies. Eric most recently served as President and CEO of Chinook Therapeutics, where he led the team to a $3.5 billion acquisition by Novartis. He’s been instrumental in raising $2 billion in equity capital and previously served as President and CEO of Silverback and COO of Seagen.  Eric is an experienced board member serving on the Boards of both public and private biotechnology companies. As we welcome Eric, we also want to thank Ravi Rao, Venture Partner, Head of Company Creation at Samsara BioCapital who previously served as Board Chair. Ravi’s leadership helped Integer establish a strong foundation essential to delivering on the promise of our science. CEO, Atul Saran, shared: “We are pleased to have graduated from Samsara’s New Company Creation program and thank Ravi for his guidance and leadership. As the next stage of our evolution, we are thrilled to welcome Eric to our Board. We look forward to the benefit of Eric’s deep expertise in building high-value businesses as we advance our programs and grow our company.”   Learn more about Eric and the rest of our board at https://lnkd.in/ep_mArAH.    #Leadership #BoardOfDirectors #Biotech #Growth #Innovation #fromstrengthtostrength #pioneeringimmunovirology #IntegerBio #multiviral 

The Marburg virus outbreak in Rwanda highlights the urgent need for treatments that can address viral threats quickly and effectively. In my team's work, we are driven by the potential to make a difference in moments like this. Using insights from immunology and virology to develop multi-viral therapies, we are working towards a future where outbreaks like this no longer instill fear, but are met with swift, effective solutions. Proud of the work that my brilliant IntegerBio team is doing to realize the potential of #immunovirology, and applaud the work that World Health Organization and the MARVAC team is doing to address this outbreak in #Rwanda. Marcus Bolton Lynn Chen Eunice Cho Wade Blair #pioneeringimmunovirology #IntegerBio #Marburg https://lnkd.in/eXeUYrKf

📣Calling experienced Antibody Discovery/Protein Engineering Scientists! IntegerBio is #hiring. We are a venture-funded #startup in Montgomery County, Maryland looking for an experienced #proteinengineer to join our growing team.     Our science is at the leading edge of #immunovirology with the potential to address high impact unmet needs. You could be part of our team where really great people (great=smart✅ hardworking✅ fun✅ caring✅) are focused on scientific excellence and a passion for patients.     ➡️If you or someone in your network is looking for a place to collaborate with colleagues and use innovative scientific expertise to deliver value to patients, you can reach us about this position at:     ▪️ workwithus@integer.bio,     ▪️ laura.frew@integer.bio,     ▪️ or, here, on LinkedIn. 👋   Learn more about us at integer.bio #cuttingedgebiology #tunetheimmunesystem #multiviraldiseases

As we approach the fall/winter season, it’s crucial to recognize the unique challenges faced by immunocompromised individuals. At Integer Bio, we’re committed to raising awareness about the heightened risks for these patients and the importance of arming humanity against viral diseases. From vaccinations to good hygiene, everyone can take action to protect those who are the most vulnerable. As we enter virus season this fall, join us in taking steps to reduce the spread of respiratory viruses and support our immunocompromised communities and loved ones during this time of heightened risk. #Immunocompromised #VirusSeason #PublicHealth #IntegerBio #pioneeringimmunovirology #RSV #influenza #respiratoryvirus